Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

por Nguyen, P L, Martin, N E, Choeurng, V, Palmer-Aronsten, B, Kolisnik, T, Beard, C J, Orio, P F, Nezolosky, M D, Chen, Y-W, Shin, H, Davicioni, E, Feng, F Y
Publicado 2017

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer

por Zhao, S G, Jackson, W C, Kothari, V, Schipper, M J, Erho, N, Evans, J R, Speers, C, Hamstra, D A, Niknafs, Y S, Nguyen, P L, Schaeffer, E M, Ross, A E, Den, R B, Klein, E A, Jenkins, R B, Davicioni, E, Feng, F Y
Publicado 2015

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk

por Ross, A E, Den, R B, Yousefi, K, Trock, B J, Tosoian, J, Davicioni, E, Thompson, D J S, Choeurng, V, Haddad, Z, Tran, P T, Trabulsi, E J, Gomella, L G, Lallas, C D, Abdollah, F, Feng, F Y, Klein, E A, Dicker, A P, Freedland, S J, Karnes, R J, Schaeffer, E M
Publicado 2016

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

por Fletcher, C. E., Deng, L., Orafidiya, F., Yuan, W., Lorentzen, M. P. G. S., Cyran, O. W., Varela-Carver, A., Constantin, T. A., Leach, D. A., Dobbs, F. M., Figueiredo, I., Gurel, B., Parkes, E., Bogdan, D., Pereira, R. R., Zhao, S. G., Neeb, A., Issa, F., Hester, J., Kudo, H., Liu, Y., Philippou, Y., Bristow, R., Knudsen, K., Bryant, R. J., Feng, F. Y., Reed, S. H., Mills, I. G., de Bono, J., Bevan, C. L.
Publicado 2022